Merck KGaA (LON: 0O14)

Market Cap	53.17B
Revenue (ttm)	17.44B
Net Income (ttm)	2.24B
Shares Out	n/a
EPS (ttm)	5.15
PE Ratio	23.70
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	Apr 29, 2024

Volume	17,134
Average Volume	172,392
Open	144.85
Previous Close	143.72
Day's Range	143.65 - 145.50
52-Week Range	112.80 - 146.53
Beta	0.71
RSI	57.17
Earnings Date	Mar 6, 2025

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing a...

• Industry: Pharmaceutical Preparations
• Founded: 1668
• Employees: 62,908
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0O14

Financial Performance

In 2023, Merck KGaA's revenue was 20.99 billion, a decrease of -5.57% compared to the previous year's 22.23 billion. Earnings were 2.82 billion, a decrease of -15.09%.

Financial numbers in EUR